Kara Olivier
Overview
Explore the profile of Kara Olivier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lage D, Burger A, Cohn J, Hernand M, Jin E, Horick N, et al.
J Pain Symptom Manage
. 2024 Aug;
68(6):613-621.e1.
PMID: 39197695
Context: Patients with advanced cancer are at increased risk for multiple hospitalizations and often have considerable needs postdischarge. Interventions to address patients' needs after transitioning home are lacking. Objectives: We...
2.
Churchill T, Smith M, Michaelson M, Lee R, Guseh J, Wasfy M, et al.
J Am Soc Echocardiogr
. 2024 Mar;
37(7):706-708.
PMID: 38499230
No abstract available.
3.
Cowan B, Olivier K, Tombal B, Wefel J
Adv Ther
. 2024 Feb;
41(4):1770-1773.
PMID: 38378976
No abstract available.
4.
Saylor P, Otani K, Balza R, Ukleja J, Pleskow H, Fisher R, et al.
JCO Precis Oncol
. 2024 Feb;
8:e2300230.
PMID: 38354328
Purpose: Radium-223 improves overall survival (OS) and reduces skeletal events in patients with bone metastatic castration-resistant prostate cancer (CRPC), but relevant biomarkers are lacking. We evaluated automated bone scan index...
5.
Cowan B, Olivier K, Tombal B, Wefel J
Adv Ther
. 2023 Nov;
41(2):476-491.
PMID: 37979089
Cognitive impairment (CI) is an issue that needs to be at the forefront of unmet healthcare needs in patients with prostate cancer (PCa) as it can negatively impact quality of...
6.
Morgans A, Renzulli 2nd J, Olivier K, Shore N
Clin Genitourin Cancer
. 2021 Apr;
19(5):467.e1-467.e11.
PMID: 33893042
Prostate cancer (PC) is primarily a disease of older men. As the risk of neurocognitive decline increases as people age, cognitive dysfunction is a potential complication in men with PC,...
7.
Spratt D, Shore N, Sartor O, Rathkopf D, Olivier K
Prostate Cancer Prostatic Dis
. 2021 Mar;
24(3):927.
PMID: 33785848
No abstract available.
8.
Spratt D, Shore N, Sartor O, Rathkopf D, Olivier K
Prostate Cancer Prostatic Dis
. 2021 Feb;
24(3):647-661.
PMID: 33603236
Background: Prostate cancer (PC) is a leading cause of death in older men. Androgen deprivation therapy (ADT) is considered the standard-of-care for men with locally advanced disease. However, continuous androgen...
9.
Saylor P, Lee R, Arora K, Deshpande V, Hu R, Olivier K, et al.
Clin Cancer Res
. 2016 Jul;
23(2):363-369.
PMID: 27440270
Purpose: The androgen receptor (AR) mRNA splice variant AR-V7 has emerged as a predictive biomarker for response to AR-targeted therapies. There are currently no commercially available assays to detect AR...
10.
Larkin J, Fishman M, Wood L, Negrier S, Olivier K, Pyle L, et al.
Am J Clin Oncol
. 2013 Jan;
37(4):397-403.
PMID: 23357974
Axitinib is a novel, oral, multitargeted tyrosine kinase inhibitor, which inhibits vascular endothelial growth factor receptors 1, 2, and 3 at subnanomolar concentrations in vitro. In the phase III clinical...